Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptorsAdriano Mollica, Romano Silvestri, Sveva Pelliccia et al.|Journal of Enzyme Inhibition and Medicinal Chemistry|2017Cited by 39
Design, Synthesis and Biological Evaluation of Two Opioid Agonist and Ca<sub>v</sub>2.2 Blocker Multitarget LigandsAdriano Mollica, Richard J. Lewis, Reza Samavati et al.|Chemical Biology & Drug Design|2014Cited by 38
Evaluation of the analgesic effect of 4-anilidopiperidine scaffold containing ureas and carbamatesLudovica Monti, Ettore Novellino, Azzurra Stefanucci et al.|Journal of Enzyme Inhibition and Medicinal Chemistry|2016Cited by 12